GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 833 filers reported holding GLAXOSMITHKLINE PLC in Q2 2020. The put-call ratio across all filers is 0.95 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $753,000 | 0.0% | 17,305 | 0.0% | 0.38% | +12.4% |
Q1 2022 | $753,000 | -1.3% | 17,305 | 0.0% | 0.34% | -0.3% |
Q4 2021 | $763,000 | +12.2% | 17,305 | -2.8% | 0.34% | +1.5% |
Q3 2021 | $680,000 | -4.1% | 17,805 | 0.0% | 0.34% | -0.6% |
Q2 2021 | $709,000 | +6.1% | 17,805 | -4.8% | 0.34% | +3.7% |
Q1 2021 | $668,000 | -6.4% | 18,705 | -3.6% | 0.32% | -14.5% |
Q4 2020 | $714,000 | -8.3% | 19,405 | -6.3% | 0.38% | -16.8% |
Q3 2020 | $779,000 | -10.8% | 20,714 | -3.3% | 0.46% | -15.4% |
Q2 2020 | $873,000 | +4.2% | 21,414 | -3.2% | 0.54% | -3.9% |
Q1 2020 | $838,000 | -19.5% | 22,114 | -0.2% | 0.56% | +6.4% |
Q4 2019 | $1,041,000 | +10.0% | 22,164 | 0.0% | 0.53% | +5.6% |
Q3 2019 | $946,000 | +6.2% | 22,164 | -0.4% | 0.50% | +5.7% |
Q2 2019 | $891,000 | +1.6% | 22,264 | +6.1% | 0.47% | +0.6% |
Q1 2019 | $877,000 | +4.4% | 20,991 | -4.5% | 0.47% | -2.1% |
Q4 2018 | $840,000 | -12.8% | 21,991 | -8.3% | 0.48% | +3.4% |
Q3 2018 | $963,000 | +0.4% | 23,991 | +0.8% | 0.46% | -5.7% |
Q2 2018 | $959,000 | +6.6% | 23,791 | +3.3% | 0.49% | +4.9% |
Q1 2018 | $900,000 | +11.2% | 23,030 | +0.9% | 0.47% | +15.0% |
Q4 2017 | $809,000 | -21.3% | 22,830 | -9.9% | 0.41% | -22.9% |
Q3 2017 | $1,028,000 | -5.9% | 25,330 | 0.0% | 0.53% | -9.3% |
Q2 2017 | $1,092,000 | +2.2% | 25,330 | 0.0% | 0.58% | +2.1% |
Q1 2017 | $1,068,000 | +12.5% | 25,330 | +2.8% | 0.57% | +7.1% |
Q4 2016 | $949,000 | -11.4% | 24,630 | -0.8% | 0.53% | -13.5% |
Q3 2016 | $1,071,000 | -1.7% | 24,830 | -1.2% | 0.62% | -1.8% |
Q2 2016 | $1,089,000 | +7.0% | 25,130 | +0.1% | 0.63% | +2.6% |
Q1 2016 | $1,018,000 | +5.5% | 25,104 | +5.0% | 0.61% | +2.0% |
Q4 2015 | $965,000 | +9.3% | 23,915 | +4.1% | 0.60% | +4.7% |
Q3 2015 | $883,000 | -11.6% | 22,965 | -0.7% | 0.57% | -2.6% |
Q2 2015 | $999,000 | +2.5% | 23,133 | +9.5% | 0.59% | +7.3% |
Q1 2015 | $975,000 | +28.8% | 21,130 | +19.2% | 0.55% | +33.1% |
Q4 2014 | $757,000 | +5.0% | 17,730 | +13.1% | 0.41% | +7.3% |
Q3 2014 | $721,000 | – | 15,680 | – | 0.38% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sio Capital Management, LLC | 325,823 | $11,557,000 | 6.52% |
KAHN BROTHERS GROUP INC | 1,139,163 | $40,406,111,000 | 6.35% |
Chubb Ltd | 400,000 | $14,188,000 | 6.18% |
Healthcare Value Capital, LLC | 50,000 | $1,774,000 | 5.40% |
CLARK ESTATES INC/NY | 650,000 | $23,056,000 | 3.81% |
PVG ASSET MANAGEMENT CORP | 220,450 | $7,819,361,000 | 3.57% |
Martin Capital Partners, LLC | 88,195 | $3,128,000 | 3.25% |
Camber Capital Management LP | 1,500,000 | $53,205,000 | 2.60% |
EQUITY INVESTMENT CORP | 2,090,120 | $74,137,000 | 2.47% |
Keystone Financial Planning, Inc. | 129,102 | $4,579,000 | 2.44% |